The hon. Lady is making an important point. Is she also mindful of the fact that, at a critical time for the future of the pharmaceuticals industry, there is currently no certainty even on cross-border production, which many of our companies are involved in, including GlaxoSmithKline in my constituency?
European Union (Withdrawal) Bill
Proceeding contribution from
Lord Walney
(Labour)
in the House of Commons on Wednesday, 13 December 2017.
It occurred during Debate on bills
and
Committee of the Whole House (HC) on European Union (Withdrawal) Bill.
About this proceeding contribution
Reference
633 c464Session
2017-19Chamber / Committee
House of Commons chamberSubjects
Librarians' tools
Timestamp
2018-09-20 12:52:50 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2017-12-13/17121336000217
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2017-12-13/17121336000217
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2017-12-13/17121336000217